U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304674) titled 'The Association Between Primary Aldosteronism and Cognitive Dysfunction' on Dec. 13.
Brief Summary: The goal of this observational study is to learn about the prevalence, progression, and influencing factors of cognitive impairment in patients with primary aldosteronism (PA). The main questions it aims to answer are:
1. What is the prevalence of baseline cognitive impairment in PA patients and what factors are associated with it?
2. What is the incidence of cognitive progression in PA patients within 1 and 5 years of follow-up and what factors influence this progression? Participants who are already diagnosed with PA as part of th...